Abstract
Since there is evidence that cholestyramine improves diarrheal states where failure of bile salt reabsorption would not appear significant, a study was undertaken to examine the effect of this resin on the toxicity and absorption of bacterial endotoxin. Both the toxicity of intraperitoneal injections of a cholestyramine-endotoxin suspension, and the absorption of the suspension through everted gut sacs was compared with a similar Dowex I-X8 suspension in rats. The results show that cholestyramine significantly reduces the toxicity of endotoxin when placed in the peritoneal cavity, and that it effectively inhibits the passage of51Cr labeled endotoxin through the intestinal wall.
Similar content being viewed by others
References
Tennent DM, Siegel J, Zanetti M, et al: Plasma cholesterol lowering action of bile acid binding polymers in experimental animals. J Lipid Res 1:469–473, 1960
Gallo DG, Bailey KR, Scheffner AL: The interaction between cholestyramine and drugs. Proc Soc Exp Biol Med 120:60–65, 1965
Bergen SS, Van Ittallie TB, Tennent DM, et al: Effect of an anion exchange resin on serum cholesterol in Man. Proc Soc Exp Biol Med 102:676–79, 1959
Hofmann AF, Poley JR: Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 281:397–402, 1969
Datta DV, Sherlock S: Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology 50:323–332, 1966
Nolan JP, Ali MV: Endotoxin and the liver. I. Toxicity in rats with choline deficient fatty livers. Proc Soc Exp Biol Med 129:29–31, 1968
Rowe GG: Control of diarrhea by cholestyramine administration. Am J Med Sci 255:84–87, 1968
Nolan JP, Ali MV: Binding of bacterial endotoxin by cholestyramine. Clin Res 18:386, 1970
Braude AI, Carey, FJ, Sutherland D, et al: Studies with radioactive endotoxin. I. The use of51Cr to label endotoxin ofescherichia coli. J Clin Invest 34:850–857, 1955
Pearson WN, Reich M: In vitro studies of 59 Fe absorption by everted intestinal sacs of the rat. J Nutr 87:117–124, 1965
Smith RT, Braude AI, Carey FJ: The distribution of Cr51 LabeledE Coli endotoxin in the generalized Shwartzman reaction. J Clin Invest 36:695–699, 1957
Armstrong C, Edwards KD: Multifactorial design for testing oral ion exchange resins, charcoal and other factors in the treatment of aspirin poisoning in the rat. Efficacy of cholestyramine. Med J Aust 2:301–303, 1967
Lutz EE, Margolis AJ: Obstetric Hepatosis: Treatment with cholestyramine and interim response to steroids. Obstet Gynecol 33:64–70, 1969
Rowe GG: Control of tenesmus and diarrhea by cholestyramine administration. Gastroenterology 53:1006, 1967
Nolan JP, Ali MV: Late effect of estrogen on endotoxin response in the rat. J Lab Clin Med 71:501–510, 1968
Wiznitzer T, Schweinburg FB, Atkins N, et al: On the relation of the size of the intraintestinal pool of endotoxin to the development of irreversibility in hemorrhagic shock. J Exp Med 112:1167–1171, 1960
Author information
Authors and Affiliations
Additional information
Supported in part by US Public Health Service Grant 1 RO1 AM-9524-01A1 and by the John A. Hartford Foundation.
Rights and permissions
About this article
Cite this article
Nolan, J.P., Ali, M.V. Effect of cholestyramine on endotoxin toxicity and absorption. Digest Dis Sci 17, 161–166 (1972). https://doi.org/10.1007/BF02232738
Issue Date:
DOI: https://doi.org/10.1007/BF02232738